To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANKHD1-EIF4EBP3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
611 representative clones for gene ANKHD1-EIF4EBP3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC144623 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 1 to 8203 1 to 8297 H1304W Y1305K K1306S F1307S C1308S ... tiling clone,   8194/8297
(98 %)
14 diff
(99.9 %id)
TI_2194697877   .a 6233 to 7405 1165 to 9   tiling clone,   1157/1246
(92 %)
22 diff
(98.3 %id)
TI_2194697393   .a 6476 to 7629 1 to 1133       1133/1250
(90 %)
19 diff
(98.5 %id)
BQ438090 leiomyosarcoma, uterus .a 6563 to 7309 1 to 749   AAA   749/924
(81 %)
22 diff
(97.7 %id)
BP298354   .a 6581 to 7163 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
TI_2194697367   .a 6661 to 7910 1240 to 7       1234/1311
(94 %)
25 diff
(98.1 %id)
CD110459 Blood vessels - aorta, basilar and artery .a 6662 to 7233 1 to 573       573/750
(76 %)
7 diff
(99.1 %id)
TI_2194697896   .a 6851 to 7373 563 to 42       520/563
(92 %)
4 diff
(99.3 %id)
CA397763 eye, RPE/choroid .a 6931 to 7489 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
CN426969 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 6952 to 7436 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BY997150   .a 6968 to 7612 10 to 654       645/654
(98 %)
11 diff
(98.4 %id)
AA249224   .a 7024 to 7192 1 to 169       169/169
(100 %)
5 diff
(97.1 %id)
BG925653 cartilage .a 7072 to 7398 70 to 396       327/344
(95 %)
8 diff
(97.7 %id)
TI_2194697401   .a 7096 to 8152 14 to 1062       1049/1272
(82 %)
12 diff
(99.1 %id)
TI_2194699708   .a 7119 to 8213 1179 to 105   tiling clone,   1075/1277
(84 %)
12 diff
(99.1 %id)
H14927 breast .a 7141 to 7323 1 to 182   fully sequenced,   182/182
(100 %)
3 diff
(98.4 %id)
N76939.
matches multiple genes
liver and spleen .a 7150 to 7318 1 to 168     also hits gene PDLIM2andC8orf58andKIAA1967 168/168
(100 %)
1 diff
(99.5 %id)
H14633 breast .a 7293 to 7778 492 to 1   fully sequenced,   492/492
(100 %)
12 diff
(97.6 %id)
AA730852 Ewing's sarcoma .a 8155 to 8338 190 to 7   tiling clone,   184/190
(96 %)
0 diff
(100 %id)
TI_151728570   .b 1 to 881 42 to 911   tiling clone, Submitted on the opposite strand 870/1001
(86 %)
22 diff
(97.9 %id)
BU737493 eye, lens .b 237 to 620 7 to 390   fully sequenced, Submitted on the opposite strand 384/390
(98 %)
6 diff
(98.5 %id)
AA521268 germinal center B cell .b 240 to 797 1 to 555     Submitted on the opposite strand 555/557
(99 %)
21 diff
(96.3 %id)
AA521283 germinal center B cell .b 240 to 797 1 to 556     Submitted on the opposite strand 556/560
(99 %)
17 diff
(97.0 %id)
BC079833 Liver, hepatocellular carcinoma .b 241 to 855 615 to 1   available from MGC, AAA Submitted on the opposite strand 615/625
(98 %)
3 diff
(99.6 %id)
BQ653205 hepatocellular carcinoma, cell line, Liver .b 241 to 853 614 to 1   available from MGC, AAA Submitted on the opposite strand 614/624
(98 %)
4 diff
(99.4 %id)
BM971728 lung .b 241 to 800 11 to 571   AAA Submitted on the opposite strand 561/571
(98 %)
6 diff
(99.0 %id)
BF224401 Kidney .b 244 to 747 1 to 504     Submitted on the opposite strand 504/504
(100 %)
3 diff
(99.5 %id)
AI884952 anaplastic oligodendroglioma, brain .b 246 to 662 1 to 417     Submitted on the opposite strand 417/417
(100 %)
5 diff
(98.9 %id)
BE673720 carcinoid, lung .b 246 to 758 1 to 513     Submitted on the opposite strand 513/513
(100 %)
1 diff
(99.9 %id)
BG654660 Pancreas, Purified pancreatic islet .b 249 to 580 1 to 332       332/332
(100 %)
0 diff
(100 %id)
AI005263 pooled .b 249 to 674 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
AI739286 colon, colon tumor, RER+ .b 249 to 636 1 to 388     Submitted on the opposite strand 388/388
(100 %)
0 diff
(100 %id)
GD137022   .b 252 to 433 187 to 6   AAA Submitted on the opposite strand 182/192
(94 %)
0 diff
(100 %id)
BC030152 Skin, melanotic melanoma, high MDR. .b 252 to 1162 911 to 1   available from MGC, AAA Submitted on the opposite strand 911/978
(93 %)
0 diff
(100 %id)
AI695265 Kidney .b 255 to 565 1 to 311     Submitted on the opposite strand 311/311
(100 %)
0 diff
(100 %id)
BQ888530 melanotic melanoma, cell line, skin .b 259 to 924 667 to 1     Submitted on the opposite strand 667/953
(69 %)
4 diff
(99.6 %id)
AA211751 muscle, skeletal muscle .b 270 to 847 1 to 574   fully sequenced, Submitted on the opposite strand 574/574
(100 %)
28 diff
(95.2 %id)
AW005984 anaplastic oligodendroglioma, brain .b 272 to 729 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
BQ184980 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 272 to 868 16 to 613   AAA Submitted on the opposite strand 598/618
(96 %)
6 diff
(99.1 %id)
TI_151808806   .b 272 to 864 669 to 77   AAA Submitted on the opposite strand 593/942
(62 %)
2 diff
(99.8 %id)
AA280513 germinal center B cell .b 273 to 550 1 to 279     Submitted on the opposite strand 279/279
(100 %)
1 diff
(99.7 %id)
BQ643922 hepatocellular carcinoma, cell line, Liver .b 293 to 853 561 to 1     Submitted on the opposite strand 561/981
(57 %)
21 diff
(97.9 %id)
BG654857 Pancreas, Purified pancreatic islet .b 335 to 865 531 to 1     Submitted on the opposite strand 531/531
(100 %)
0 diff
(100 %id)
BG760967 melanotic melanoma, high MDR (cell line), skin .b 356 to 1163 805 to 1   tiling clone, available from MGC, Submitted on the opposite strand 805/875
(92 %)
18 diff
(98.0 %id)
BM820685 Ascites, stomach .b 380 to 816 437 to 1     Submitted on the opposite strand 437/437
(100 %)
0 diff
(100 %id)
BQ276378 carcinoma, cell line, Prostate .b 416 to 856 451 to 1     Submitted on the opposite strand 451/971
(46 %)
17 diff
(98.3 %id)
BI194862 brain, neuroblastoma .b 449 to 1118 668 to 2     Submitted on the opposite strand 667/668
(99 %)
0 diff
(100 %id)
BM699671 eye, lens .b 590 to 1094 505 to 1   fully sequenced, Submitted on the opposite strand 505/505
(100 %)
2 diff
(99.7 %id)
BI116140 lung, small cell carcinoma .b 604 to 1167 583 to 2     Submitted on the opposite strand 582/765
(76 %)
0 diff
(100 %id)
BM729278 eye, fetal eye .b 608 to 1121 514 to 1     Submitted on the opposite strand 514/514
(100 %)
0 diff
(100 %id)
BM911064 astrocytoma grade IV, cell line, brain .b 614 to 1116 511 to 9     Submitted on the opposite strand 503/1072
(46 %)
0 diff
(100 %id)
AA213957 muscle, skeletal muscle .b 640 to 840 195 to 1   fully sequenced, Submitted on the opposite strand 195/195
(100 %)
5 diff
(97.5 %id)
W28294 eye, retina .b 716 to 1123 414 to 12       403/439
(91 %)
0 diff
(100 %id)
AA282265 germinal center B cell .b 769 to 1234 465 to 1     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
AW294901   .b 885 to 1157 20 to 292     Submitted on the opposite strand 273/302
(90 %)
1 diff
(99.7 %id)
DB078493 testis .b 978 to 1544 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DB067539 testis .b 1350 to 1898 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DA509209 brain .b 1549 to 2122 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA462281 tongue, tumor tissue .b 1568 to 2002 2 to 436   capped   435/435
(100 %)
0 diff
(100 %id)
DA583835 lung .b 1568 to 2123 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA818386   .b 1568 to 2091 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA997797   .b 1568 to 1984 2 to 418   capped   417/417
(100 %)
0 diff
(100 %id)
DB066335 testis .b 1568 to 2022 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
DB228455 trachea .b 1568 to 2131 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB283594 uterus .b 1568 to 2100 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB129399 thymus .b 1572 to 2113 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA239060 brain .b 1576 to 2143 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA654970   .b 1578 to 2032 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
NM_020690.4   .b 1578 to 9896 1 to 8319 exact RefSeq,   8319/8319
(100 %)
0 diff
(100 %id)
BP365396 lung .b 1578 to 2162 1 to 585       585/593
(98 %)
1 diff
(99.9 %id)
DA442165 tongue, tumor tissue .b 1579 to 2161 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA859680 placenta .b 1579 to 2034 2 to 457   capped   456/456
(100 %)
0 diff
(100 %id)
DA953769 Spleen .b 1579 to 2132 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB068892 testis .b 1579 to 2124 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BI759720 pooled colon, kidney, stomach .b 1580 to 2290 1 to 711       711/711
(100 %)
0 diff
(100 %id)
CX164935 human embryonic stem cells differentiated toan early endodermal cell type .b 1588 to 2380 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
DA329045 hippocampus .b 1590 to 2140 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
CN258706 embryonic stem cells, cell lines H1, H7, andH9 .b 1590 to 1980 1 to 391       391/391
(100 %)
0 diff
(100 %id)
BQ954459 brain, neuroblastoma, cell line .b 1590 to 2468 1 to 884       884/908
(97 %)
21 diff
(97.7 %id)
BX342815   .b 1591 to 2469 1 to 877       877/956
(91 %)
8 diff
(99.2 %id)
BU553036 ovary, teratocarcinoma, cell line .b 1591 to 2401 1 to 817       817/937
(87 %)
11 diff
(98.9 %id)
BU183542 melanotic melanoma, skin .b 1598 to 2316 1 to 722       722/887
(81 %)
19 diff
(97.9 %id)
BU857815 adenocarcinoma, cell line, breast .b 1599 to 2419 1 to 827       827/953
(86 %)
30 diff
(96.9 %id)
BU158506 large cell carcinoma, lung .b 1600 to 2389 1 to 793       793/904
(87 %)
10 diff
(98.9 %id)
DA744822   .b 1601 to 2166 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA998541   .b 1603 to 1876 2 to 275   capped   274/274
(100 %)
0 diff
(100 %id)
TI_2194695760   .b 1608 to 2665 88 to 1153       1066/1157
(92 %)
24 diff
(98.0 %id)
TI_2194695772   .b 1608 to 2730 86 to 1207       1122/1208
(92 %)
34 diff
(97.2 %id)
TI_2194699328   .b 1608 to 2466 89 to 945       857/1126
(76 %)
33 diff
(97.1 %id)
DA302507 hippocampus .b 1618 to 2216 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA670071   .b 1629 to 1989 2 to 362   capped   361/361
(100 %)
0 diff
(100 %id)
DB240168 trachea .b 1629 to 2196 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA442111 tongue, tumor tissue .b 1641 to 2231 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
AF521883   .b 1642 to 9887 1 to 8246 exact tiling clone,   8246/8246
(100 %)
2 diff
(100.0 %id)
BE622326 melanotic melanoma, skin .b 1663 to 2434 1 to 774       774/909
(85 %)
35 diff
(96.2 %id)
BQ711518 Spleen .b 1725 to 2608 1 to 893       893/920
(97 %)
36 diff
(96.1 %id)
DA737578   .b 1804 to 2535 2 to 734   capped   733/733
(100 %)
4 diff
(99.5 %id)
CX761389 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1855 to 2569 1 to 715     Submitted on the opposite strand 715/715
(100 %)
7 diff
(99.1 %id)
BU170010 large cell carcinoma, lung .b 1869 to 2615 1 to 751       751/926
(81 %)
8 diff
(99.2 %id)
AA581023 bulk germ cell seminoma .b 2041 to 2148 1 to 108       108/108
(100 %)
0 diff
(100 %id)
DB177311 kidney, tumor tissue .b 2055 to 2601 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BM466796 eye, retinoblastoma .b 2160 to 3061 8 to 924       917/1075
(85 %)
42 diff
(96.1 %id)
BX372288   .b 2180 to 3122 936 to 1       936/936
(100 %)
21 diff
(97.8 %id)
TI_2194697392   .b 2246 to 3340 2 to 1076       1075/1259
(85 %)
14 diff
(98.9 %id)
TI_1948079588   .b 2278 to 3182 129 to 1031       903/1404
(64 %)
15 diff
(99.0 %id)
TI_1948079938   .b 2278 to 3379 131 to 1217       1089/1400
(77 %)
69 diff
(95.1 %id)
BM453065 leiomyosarcoma, uterus .b 2281 to 3160 1 to 899       899/1046
(85 %)
23 diff
(97.9 %id)
CR989536 T-Lymphocytes .b 2383 to 3303 1 to 921       921/921
(100 %)
4 diff
(99.6 %id)
CB148570 Liver .b 2390 to 2954 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BU858283 adenocarcinoma, cell line, breast .b 2392 to 3253 1 to 869       869/870
(99 %)
12 diff
(98.7 %id)
BU860313 adenocarcinoma, cell line, breast .b 2393 to 3239 1 to 858       858/859
(99 %)
19 diff
(97.8 %id)
BU538428 adenocarcinoma, cell line, breast .b 2430 to 3366 1 to 939       939/940
(99 %)
11 diff
(98.9 %id)
BP286000 lung .b 2506 to 3101 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BQ956941 brain, neuroblastoma, cell line .b 2529 to 3451 1 to 926       926/926
(100 %)
17 diff
(98.2 %id)
BQ924338 brain, neuroblastoma, cell line .b 2590 to 3475 1 to 893       894/901
(99 %)
21 diff
(97.7 %id)
DA735590   .b 2690 to 3543 2 to 851   capped   850/857
(99 %)
7 diff
(99.2 %id)
TI_2194697305   .b 2703 to 3874 1 to 1158       1158/1299
(89 %)
22 diff
(98.4 %id)
BI261414 lymph, lymphoma, cell line .b 2867 to 3352 1 to 497       497/497
(100 %)
17 diff
(96.6 %id)
DA254233 caudate nucleus .b 2903 to 3460 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
TI_2194697306   .b 3039 to 4196 9 to 1156       1148/1299
(88 %)
16 diff
(98.8 %id)
TI_2194697404   .b 3059 to 4277 1219 to 23       1197/1271
(94 %)
21 diff
(98.4 %id)
BQ433865 melanotic melanoma, skin .b 3080 to 3937 12 to 870       859/871
(98 %)
14 diff
(98.4 %id)
CN258707 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3140 to 3855 1 to 716       716/716
(100 %)
0 diff
(100 %id)
CN258703 embryonic stem cells, DMSO-treated H9 cellline .b 3217 to 3551 1 to 335       335/335
(100 %)
0 diff
(100 %id)
DB172646 kidney, tumor tissue .b 3218 to 3813 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA743629   .b 3566 to 4118 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BU603092 mixed (pool of 40 RNAs) .b 3567 to 4416 8 to 874       867/875
(99 %)
45 diff
(94.9 %id)
DR763252 embryonic stem .b 3677 to 4459 1 to 783       783/783
(100 %)
0 diff
(100 %id)
BF026849 melanotic melanoma, skin .b 3700 to 4201 1 to 498   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 498/1012
(49 %)
7 diff
(99.4 %id)
AK000904 whole embryo, mainly head .b 3708 to 5267 1 to 1560   available from FLJ,   1560/1560
(100 %)
0 diff
(100 %id)
DA656677   .b 3712 to 4292 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
TI_2194697308   .b 3773 to 4768 19 to 1013       995/1244
(79 %)
9 diff
(99.3 %id)
AL045501 testis .b 3847 to 4544 1 to 698       698/698
(100 %)
0 diff
(100 %id)
TI_2194697369   .b 3938 to 4887 961 to 13       949/1234
(76 %)
5 diff
(99.6 %id)
CV570226 cornea, eye .b 3951 to 4061 1 to 111       111/111
(100 %)
0 diff
(100 %id)
TI_2194697316   .b 4055 to 5207 11 to 1155       1145/1332
(85 %)
18 diff
(98.7 %id)
BU145354 melanotic melanoma, cell line, skin .b 4118 to 4929 1 to 820       818/881
(92 %)
28 diff
(96.9 %id)
TI_2194697368   .b 4135 to 5336 1191 to 5       1187/1294
(91 %)
15 diff
(98.9 %id)
BQ706991 Spleen .b 4184 to 5104 1 to 925       925/925
(100 %)
7 diff
(99.3 %id)
AU117658 whole embryo, mainly head .b 4208 to 4946 2 to 739   capped   738/741
(99 %)
3 diff
(99.6 %id)
DA015962 adrenal gland .b 4215 to 4777 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BQ439257 embryonal carcinoma, cell line, testis .b 4228 to 5101 1 to 882       882/882
(100 %)
11 diff
(98.8 %id)
CX782289 human embryonic stem cells .b 4266 to 5101 1 to 836       836/836
(100 %)
2 diff
(99.8 %id)
AU125326   .b 4274 to 5112 2 to 836   capped   835/845
(98 %)
12 diff
(98.6 %id)
DB185141 liver, tumor tissue .b 4314 to 4886 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BQ215507 embryonal carcinoma, cell line, testis .b 4364 to 5178 1 to 823       823/890
(92 %)
12 diff
(98.7 %id)
AF217646   .b 4469 to 6068 1 to 1600   tiling clone,   1600/1600
(100 %)
0 diff
(100 %id)
CR990939 T-Lymphocytes .b 4531 to 5343 1 to 814       814/814
(100 %)
2 diff
(99.8 %id)
BM551773 melanotic melanoma, skin .b 4624 to 5461 1 to 853       853/1103
(77 %)
17 diff
(98.5 %id)
TI_2194697341   .b 4627 to 5753 1214 to 5       1210/1303
(92 %)
18 diff
(98.7 %id)
TI_2194697347   .b 4729 to 5610 5 to 884       880/1254
(70 %)
6 diff
(99.6 %id)
TI_2194697881   .b 4734 to 5872 1229 to 6       1224/1297
(94 %)
22 diff
(98.4 %id)
CB163696 Liver .b 4748 to 5256 1 to 509       509/509
(100 %)
0 diff
(100 %id)
DA855808 placenta .b 4882 to 5317 2 to 437   capped   436/438
(99 %)
1 diff
(99.8 %id)
AA044837 uterus .b 4903 to 5586 1 to 670       670/674
(99 %)
16 diff
(97.7 %id)
BM040711 Kidney, Wilms' tumor, cell line .b 4959 to 5569 1 to 609   fully sequenced,   609/609
(100 %)
5 diff
(99.2 %id)
FN054209 breast carcinoma .b 5020 to 5122 1 to 103       103/103
(100 %)
0 diff
(100 %id)
CV412486 denis_drash .b 5027 to 5435 427 to 1     Submitted on the opposite strand 382/448
(85 %)
41 diff
(90.9 %id)
FN053961 breast carcinoma .b 5153 to 5246 92 to 1     Submitted on the opposite strand 92/94
(97 %)
3 diff
(96.9 %id)
DA376907 thalamus .b 5158 to 5712 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
FN092326 breast carcinoma .b 5158 to 5232 79 to 2     Submitted on the opposite strand 78/80
(97 %)
0 diff
(100 %id)
FN057183 breast carcinoma .b 5213 to 5315 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BM806997 duodenal adenocarcinoma, cell line, small intestine .b 5221 to 6172 21 to 984       964/1050
(91 %)
25 diff
(97.7 %id)
TI_2194697365   .b 5248 to 6293 15 to 1128       1011/1263
(80 %)
54 diff
(95.8 %id)
TI_2194697353   .b 5258 to 6360 1194 to 14       1181/1268
(93 %)
25 diff
(98.1 %id)
AA947622 Kidney, kidney tumor .b 5260 to 5666 407 to 1       407/407
(100 %)
0 diff
(100 %id)
BI262037 lymph, lymphoma, cell line .b 5260 to 6023 771 to 8       766/776
(98 %)
4 diff
(99.5 %id)
FN050814 breast carcinoma .b 5261 to 5333 73 to 1     Submitted on the opposite strand 73/73
(100 %)
0 diff
(100 %id)
CN277030 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 5286 to 6066 1 to 781       781/781
(100 %)
1 diff
(99.9 %id)
CR994203 T-Lymphocytes .b 5302 to 5857 1 to 556       556/556
(100 %)
0 diff
(100 %id)
CD105654 brain, Pituitary .b 5309 to 6078 26 to 796   AAA   771/965
(79 %)
21 diff
(97.9 %id)
CX782220 human embryonic stem cells .b 5315 to 6086 773 to 1       773/773
(100 %)
6 diff
(99.3 %id)
BU627183 Bone, Enchondroma cell line .b 5328 to 6061 747 to 19   AAA   729/729
(100 %)
6 diff
(99.2 %id)
CB162217 Liver .b 5331 to 5943 1 to 613       613/613
(100 %)
0 diff
(100 %id)
CA429034 Cell Line, Chondrosarcoma .b 5354 to 6077 725 to 3       723/727
(99 %)
1 diff
(99.9 %id)
BM794211 Ascites, stomach .b 5371 to 5943 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BQ187900 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 5383 to 5692 1 to 310   fully sequenced,   310/310
(100 %)
1 diff
(99.7 %id)
CA438127 lung, Metastatic Chondrosarcoma .b 5407 to 6073 666 to 1       666/666
(100 %)
4 diff
(99.4 %id)
CN278208 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 5423 to 6051 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BQ019580 Chondrosarcoma, Left Pubic Bone .b 5425 to 6061 653 to 17   AAA   637/640
(99 %)
1 diff
(99.9 %id)
BM147353 leukopheresis .b 5472 to 5971 1 to 500       500/500
(100 %)
0 diff
(100 %id)
AI683970 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 5488 to 6062 575 to 1       575/575
(100 %)
0 diff
(100 %id)
BQ433415 embryonal carcinoma, cell line, testis .b 5489 to 6080 1 to 592   AAA   592/592
(100 %)
0 diff
(100 %id)
AU154600   .b 5499 to 6061 563 to 1       563/564
(99 %)
6 diff
(99.0 %id)
BF062373 pooled germ cell tumors .b 5524 to 6080 557 to 1       557/557
(100 %)
0 diff
(100 %id)
BM041470 Kidney, Wilms' tumor, cell line .b 5539 to 5984 448 to 1   fully sequenced,   448/448
(100 %)
2 diff
(99.6 %id)
DB355552 whole embryo, mainly head .b 5547 to 6080 534 to 1       534/536
(99 %)
3 diff
(99.5 %id)
DB362986   .b 5570 to 6112 543 to 1       543/543
(100 %)
8 diff
(98.6 %id)
BG291245 bladder, transitional cell papilloma, cell line .b 5572 to 6364 1 to 789       788/852
(92 %)
26 diff
(97.0 %id)
AW104565 pooled .b 5575 to 6076 502 to 1       502/502
(100 %)
4 diff
(99.3 %id)
AA044812 uterus .b 5608 to 6074 467 to 1       467/467
(100 %)
4 diff
(99.2 %id)
AA837095 germinal center B cell .b 5621 to 6077 461 to 2       460/461
(99 %)
35 diff
(92.5 %id)
AI360066 anaplastic oligodendroglioma, brain .b 5622 to 6080 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AI657062 pooled germ cell tumors .b 5624 to 6080 457 to 1       457/457
(100 %)
0 diff
(100 %id)
TI_2194697343   .b 5634 to 6765 1136 to 11       1126/1318
(85 %)
12 diff
(99.1 %id)
AA653147   .b 5646 to 6080 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AA621519   .b 5653 to 6068 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AI283421 pooled .b 5656 to 6069 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AL045502 testis .b 5658 to 6043 393 to 6       388/393
(98 %)
3 diff
(99.3 %id)
AL046315 testis .b 5659 to 6040 1 to 383     Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 383/383
(100 %)
2 diff
(99.5 %id)
BQ185618 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 5662 to 6092 429 to 1   fully sequenced,   429/429
(100 %)
3 diff
(99.4 %id)
AI830645 2 pooled tumors (clear cell type), Kidney .b 5687 to 6077 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AI401715 Prostate .b 5694 to 6080 387 to 1       387/387
(100 %)
0 diff
(100 %id)
TI_2194697875   .b 5741 to 6823 1087 to 12       1078/1089
(98 %)
35 diff
(96.8 %id)
DB367890   .b 5812 to 6330 520 to 1       520/522
(99 %)
8 diff
(98.5 %id)
DA756176   .b 5820 to 6402 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
AI827947 anaplastic oligodendroglioma, brain .b 5841 to 6330 490 to 1       490/490
(100 %)
0 diff
(100 %id)
DA245657 brain .b 5871 to 6466 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
CR996669 T-Lymphocytes .b 5902 to 6767 1 to 866       866/867
(99 %)
2 diff
(99.8 %id)
AI658864 Prostate .b 5917 to 6330 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AI523142 aorta .b 5980 to 6073 94 to 1       94/94
(100 %)
0 diff
(100 %id)
TI_2194697345   .b 6032 to 7186 1 to 1145       1145/1319
(86 %)
18 diff
(98.7 %id)
CV570797 cornea, eye .b 6038 to 6666 1 to 630       630/630
(100 %)
5 diff
(99.3 %id)
FN171196 breast carcinoma .b 6085 to 6186 99 to 1     Submitted on the opposite strand 99/100
(99 %)
7 diff
(93.0 %id)
TI_2194697307   .b 6140 to 7330 1180 to 6       1175/1283
(91 %)
20 diff
(98.5 %id)
DA460885 tongue, tumor tissue .b 6347 to 6907 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BG697922 skin .b 6352 to 7137 1 to 787   available from MGC,   787/787
(100 %)
2 diff
(99.8 %id)
TI_149279947   .b 6370 to 7206 897 to 61   AAA   837/1128
(74 %)
36 diff
(96.9 %id)
DB063752 testis .b 6375 to 6917 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA413389 thalamus .b 6378 to 6941 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA583427 lung .b 6379 to 6975 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA757463   .b 6396 to 6963 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB229402 trachea .b 6396 to 6940 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BE887901 leiomyosarcoma, uterus .b 6407 to 7176 1 to 777       777/828
(93 %)
28 diff
(96.7 %id)
AI224516 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6420 to 6896 477 to 1       477/477
(100 %)
0 diff
(100 %id)
BG260637 bladder, transitional cell papilloma, cell line .b 6446 to 7214 1 to 755       755/944
(79 %)
9 diff
(99.1 %id)
CN357750 embryonic stem cells, cell lines H1, H7, andH9 .b 6452 to 6942 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BM828508 Ascites, stomach .b 6479 to 7175 1 to 697       697/697
(100 %)
0 diff
(100 %id)
DB159606 thymus .b 6483 to 7077 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
BE172980 head_neck .b 6505 to 6767 1 to 263       263/263
(100 %)
0 diff
(100 %id)
TI_1948088047   .b 6539 to 7313 119 to 897       779/1384
(56 %)
35 diff
(97.5 %id)
DB193903 ovary, tumor tissue .b 6539 to 7106 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
TI_2194697351   .b 6579 to 7600 1 to 1019       1019/1251
(81 %)
8 diff
(99.4 %id)
DA117360 cerebellum .b 6595 to 7143 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
TI_154168457   .b 6619 to 7417 95 to 907       813/813
(100 %)
43 diff
(94.8 %id)
CB854449 lung, Primary Lung Epithelial Cells .b 6632 to 7206 593 to 19   AAA   575/575
(100 %)
1 diff
(99.9 %id)
TI_2194697878   .b 6641 to 7472 871 to 40       832/1258
(66 %)
8 diff
(99.4 %id)
AI613096 Kidney .b 6739 to 7207 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AA625593 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6758 to 6897 140 to 1       140/140
(100 %)
0 diff
(100 %id)
DA873618 Prostate .b 6781 to 7341 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
TI_2194697304   .b 6787 to 7955 1168 to 4       1165/1328
(87 %)
10 diff
(99.3 %id)
BG258979 embryonal carcinoma, cell line, testis .b 6898 to 7703 1 to 801       801/806
(99 %)
26 diff
(96.8 %id)
CD243126 brain, Pituitary .b 7006 to 7771 1 to 772       772/887
(87 %)
9 diff
(99.0 %id)
CD630321   .b 7018 to 7664 1 to 648       648/666
(97 %)
2 diff
(99.7 %id)
TI_2194697349   .b 7034 to 8237 1 to 1184       1184/1287
(91 %)
29 diff
(97.8 %id)
BP293308 lung .b 7053 to 7634 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA795923 brain .b 7081 to 7614 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DB151943 thymus .b 7105 to 7565 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
DA343792 substantia nigra .b 7116 to 7681 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA581607 lung .b 7117 to 7669 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BM917470 blood, natural killer cells, cell line .b 7147 to 7836 1 to 698       698/1137
(61 %)
14 diff
(98.8 %id)
DB185114 liver, tumor tissue .b 7192 to 7756 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB185160 liver, tumor tissue .b 7192 to 7759 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA763596 tongue .b 7193 to 7770 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BP243928 Liver .b 7195 to 7770 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DA381259 thalamus .b 7197 to 7737 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA794639 brain .b 7241 to 7805 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
TI_2194697320   .b 7247 to 8465 1209 to 8       1202/1295
(92 %)
0 diff
(100 %id)
BM476743 leiomyosarcoma, uterus .b 7269 to 8175 9 to 922       914/1085
(84 %)
6 diff
(99.5 %id)
DA950868 Spleen .b 7274 to 7839 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CX787397 human embryonic stem cells .b 7283 to 7912 1 to 630       630/630
(100 %)
0 diff
(100 %id)
TI_2194697880   .b 7305 to 7959 684 to 28       657/684
(96 %)
0 diff
(100 %id)
TI_2194697895   .b 7311 to 8473 1163 to 7       1157/1302
(88 %)
0 diff
(100 %id)
DA931698 Spleen .b 7372 to 7929 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB005995 breast, tumor tissue .b 7400 to 7943 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA086042 cerebellum .b 7413 to 7992 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CT003138 T-Lymphocytes .b 7483 to 8387 1 to 905       905/907
(99 %)
3 diff
(99.7 %id)
BP345777 synovial membrane .b 7557 to 8134 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BP346454 synovial membrane .b 7557 to 8135 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BI910570 leukocyte .b 7565 to 8427 1 to 885       885/1055
(83 %)
53 diff
(95.0 %id)
BU186456 large cell carcinoma, lung .b 7604 to 8361 1 to 761       761/868
(87 %)
8 diff
(99.1 %id)
DB121486 thymus .b 7629 to 8180 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA877732 Prostate .b 7630 to 8197 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BP291384 lung .b 7642 to 8226 1 to 585       585/585
(100 %)
0 diff
(100 %id)
TI_2194697390   .b 7643 to 8687 1 to 1033       1033/1251
(82 %)
23 diff
(98.2 %id)
DB125575 thymus .b 7677 to 8250 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
TI_159677548   .b 7767 to 8623 50 to 899       850/1036
(82 %)
27 diff
(97.4 %id)
DA426506 colon .b 7855 to 8424 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB110458 thymus .b 7876 to 8454 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA427245 colon .b 7945 to 8497 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA839277 placenta .b 7962 to 8517 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CF272490 Brain glioblastoma .b 7995 to 8829 1 to 844       844/862
(97 %)
12 diff
(98.7 %id)
CB114977 Liver .b 8001 to 8499 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BX459123 placenta .b 8176 to 9037 1 to 861       861/861
(100 %)
1 diff
(99.9 %id)
CN426968 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 8304 to 8608 1 to 305       305/305
(100 %)
0 diff
(100 %id)
BM709417 eye, optic nerve .b 8511 to 8794 1 to 284     Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 284/284
(100 %)
0 diff
(100 %id)
DR422380 eye, Pterygium .b 8576 to 9203 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BG698049 skin .b 8618 to 9487 1 to 873       873/877
(99 %)
16 diff
(98.2 %id)
TI_2194695784   .b 8707 to 9769 1172 to 107       1066/1292
(82 %)
41 diff
(96.9 %id)
TI_2194695796   .b 8774 to 9769 1099 to 105       995/1234
(80 %)
16 diff
(98.8 %id)
AA370905 Prostate .b 8890 to 9141 1 to 252       252/252
(100 %)
0 diff
(100 %id)
CR988853 T-Lymphocytes .b 8932 to 9717 1 to 787       787/787
(100 %)
4 diff
(99.5 %id)
BX430912 placenta .b 8936 to 9768 1 to 835       835/835
(100 %)
10 diff
(98.9 %id)
TI_2194697302   .b 8946 to 9769 992 to 171       822/1256
(65 %)
3 diff
(99.8 %id)
CN426966 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 8985 to 9597 1 to 613       613/613
(100 %)
0 diff
(100 %id)
TI_2194697318   .b 9056 to 9769 16 to 729       714/1275
(56 %)
13 diff
(99.0 %id)
AA251250 germinal center B cell .b 9086 to 9417 1 to 333   fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 333/333
(100 %)
1 diff
(99.7 %id)
TI_154115878   .b 9105 to 9891 871 to 92   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 780/807
(96 %)
16 diff
(98.1 %id)
BE882112 leiomyosarcoma, uterus .b 9114 to 9869 1 to 754       754/798
(94 %)
17 diff
(97.9 %id)
TI_149286101   .b 9123 to 9891 853 to 89   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 765/805
(95 %)
16 diff
(98.1 %id)
AL046316 testis .b 9143 to 9891 773 to 25   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 749/751
(99 %)
1 diff
(99.9 %id)
AA383191 testis .b 9146 to 9432 1 to 287       287/287
(100 %)
0 diff
(100 %id)
CB158942 Liver .b 9146 to 9628 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BU733356 eye, optic nerve .b 9195 to 9891 709 to 15   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 695/695
(100 %)
3 diff
(99.6 %id)
BM787922 stomach .b 9214 to 9636 1 to 423       423/423
(100 %)
0 diff
(100 %id)
AA056040 heart .b 9245 to 9497 1 to 253   fully sequenced,   253/253
(100 %)
0 diff
(100 %id)
AA233687 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 9335 to 9582 1 to 247   fully sequenced,   247/247
(100 %)
1 diff
(99.6 %id)
BU944670 adenocarcinoma, cell line, breast .b 9354 to 9887 1 to 534   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 534/534
(100 %)
0 diff
(100 %id)
BU955988 adenocarcinoma, cell line, breast .b 9354 to 9891 1 to 538   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 538/538
(100 %)
0 diff
(100 %id)
BM726079 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 9355 to 9893 1 to 539   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 539/539
(100 %)
1 diff
(99.9 %id)
AI625664 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 9380 to 9891 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AA251115 germinal center B cell .b 9387 to 9887 523 to 23   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 501/501
(100 %)
5 diff
(99.1 %id)
BP420017 small intestine .b 9412 to 9887 502 to 27   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 476/476
(100 %)
0 diff
(100 %id)
BM682514 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 9451 to 9891 459 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
AA056011 heart .b 9467 to 9892 429 to 1   fully sequenced,   429/429
(100 %)
3 diff
(99.4 %id)
AA233617 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 9521 to 9891 371 to 1   fully sequenced,   371/371
(100 %)
0 diff
(100 %id)
BQ003749 Chondrosarcoma, Left Pelvis .b 9541 to 9891 365 to 15   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
DA572270 whole embryo, mainly body .c 1 to 783 2 to 783   tiling clone, capped   782/787
(99 %)
15 diff
(98.1 %id)
AK074173 Spleen .c 6 to 4540 1 to 4535   tiling clone, available from FLJ,   4535/4535
(100 %)
0 diff
(100 %id)
CR980383 T-Lymphocytes .c 1270 to 2131 1 to 865       865/865
(100 %)
6 diff
(99.4 %id)
DA527732 brain .c 1345 to 1915 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DN990809 brain, whole brain .c 1507 to 1985 8 to 486       479/486
(98 %)
6 diff
(98.8 %id)
DA552916   .c 1512 to 2070 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BX509954   .c 1661 to 2406 1 to 746       746/746
(100 %)
1 diff
(99.9 %id)
AY070436 brain .c 1697 to 4819 1 to 3124       3124/3124
(100 %)
1 diff
(100.0 %id)
CB150463 cervix, Uterine .c 1730 to 2294 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
CN258701 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1778 to 2066 1 to 289       289/289
(100 %)
0 diff
(100 %id)
AU146571 whole embryo, mainly body .c 3996 to 4540 545 to 1       545/546
(99 %)
8 diff
(98.6 %id)
BC073958 Skin, melanotic melanoma. .c 4213 to 8298 1 to 4086   tiling clone, AAA   4086/4366
(93 %)
5 diff
(99.9 %id)
AL136943 uterus .c 4891 to 8291 1 to 3401   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 3401/3401
(100 %)
1 diff
(100.0 %id)
NM_017747.1   .d 1 to 8196 1 to 8196 exact RefSeq,   8196/8196
(100 %)
5 diff
(100.0 %id)
AF521882   .d 65 to 8184 1 to 8120 exact tiling clone,   8120/8120
(100 %)
1 diff
(100.0 %id)
DA198379 brain .d 5022 to 5573 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AA243549 germinal center B cell .d 6744 to 7065 1 to 322       322/322
(100 %)
1 diff
(99.7 %id)
DR761118 embryonic stem .d 6981 to 7738 1 to 758       758/758
(100 %)
0 diff
(100 %id)
TI_151736570   .d 7156 to 7841 765 to 75       691/1057
(65 %)
12 diff
(98.9 %id)
AA057050 uterus .d 7188 to 7396 1 to 207       207/207
(100 %)
4 diff
(98.1 %id)
CB163900 Liver .d 7208 to 7804 1 to 597       597/597
(100 %)
0 diff
(100 %id)
TI_154056412   .d 7342 to 8187 945 to 110   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 836/974
(85 %)
15 diff
(98.5 %id)
BU620758 cell lines, Chondrosarcoma .d 7397 to 8184 803 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 785/789
(99 %)
3 diff
(99.7 %id)
CA428556 cell lines, Chondrosarcoma .d 7431 to 8187 772 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 754/754
(100 %)
4 diff
(99.5 %id)
BQ002862 Chondrosarcoma, Left Pelvis .d 7445 to 8171 755 to 29   AAA   727/737
(98 %)
1 diff
(99.9 %id)
CD105644 brain, Pituitary .d 7475 to 8184 1 to 712   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 712/712
(100 %)
4 diff
(99.5 %id)
BQ447032 Knee, Osteoarthritic Cartilage .d 7515 to 8184 688 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 670/670
(100 %)
0 diff
(100 %id)
CA418884 Chondrosarcoma Grade II, Left Pelvis .d 7526 to 8187 680 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
N37001 melanocyte .d 7527 to 8184 649 to 1       649/683
(95 %)
24 diff
(96.5 %id)
AW166110 brain, medulloblastoma .d 7529 to 8187 659 to 1       659/671
(98 %)
2 diff
(99.8 %id)
AW771588 Kidney .d 7532 to 8184 653 to 1       653/653
(100 %)
1 diff
(99.9 %id)
AI653346 pooled germ cell tumors .d 7536 to 8188 681 to 30       652/682
(95 %)
7 diff
(99.0 %id)
CA429645 Cell Line, Chondrosarcoma .d 7536 to 8184 667 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
AW978728   .d 7598 to 8184 592 to 2     Submitted on the opposite strand 591/612
(96 %)
15 diff
(97.6 %id)
FN061081 breast carcinoma .d 7598 to 7699 1 to 102       102/102
(100 %)
0 diff
(100 %id)
AI433670 Kidney .d 7600 to 8189 590 to 1       590/590
(100 %)
0 diff
(100 %id)
BM750176 stomach .d 7617 to 8184 1 to 568       568/569
(99 %)
3 diff
(99.5 %id)
DB367724   .d 7640 to 8178 548 to 8       541/548
(98 %)
5 diff
(99.1 %id)
CA428501 cell lines, Chondrosarcoma .d 7647 to 8187 559 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 541/541
(100 %)
9 diff
(98.4 %id)
N98820 multiple sclerosis lesions .d 7652 to 7974 1 to 327   fully sequenced,   327/327
(100 %)
4 diff
(98.8 %id)
BM689448 eye, Retina Foveal and Macular .d 7653 to 8087 9 to 443       435/443
(98 %)
6 diff
(98.7 %id)
DB303865 brain .d 7654 to 8184 531 to 1       531/531
(100 %)
2 diff
(99.7 %id)
CD677511 eye, Trabecular meshwork .d 7655 to 8184 1 to 530   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 530/530
(100 %)
0 diff
(100 %id)
CD677537 eye, Trabecular meshwork .d 7655 to 8184 1 to 530   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 530/530
(100 %)
0 diff
(100 %id)
AA778393 heart .d 7669 to 8189 521 to 1       521/521
(100 %)
0 diff
(100 %id)
BM148639 leukopheresis .d 7691 to 8191 512 to 13       500/519
(96 %)
0 diff
(100 %id)
AA812882   .d 7694 to 8191 500 to 2       499/500
(99 %)
0 diff
(100 %id)
BP394698 pancreatic islet .d 7695 to 8191 1 to 497   tiling clone, Submitted on the opposite strand 497/501
(99 %)
1 diff
(99.9 %id)
DW412343 Liver .d 7697 to 8004 17 to 324       308/324
(95 %)
6 diff
(98.2 %id)
DW434760 Liver .d 7697 to 7937 17 to 257       241/257
(93 %)
6 diff
(97.7 %id)
AA553738 breast .d 7712 to 8183 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
BP304574   .d 7727 to 8184 1 to 458   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
AI336544 adenocarcinoma, colon .d 7744 to 8187 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
N32978 melanocyte .d 7746 to 8184 441 to 1       441/443
(99 %)
2 diff
(99.6 %id)
AA731151 germinal center B cell .d 7748 to 8184 457 to 21   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 437/437
(100 %)
0 diff
(100 %id)
BF889074 testis_normal .d 7750 to 8007 272 to 18     Submitted on the opposite strand 255/272
(93 %)
0 diff
(100 %id)
AA772089 parathyroid gland, parathyroid tumor .d 7751 to 8186 441 to 6       436/441
(98 %)
0 diff
(100 %id)
AI028365   .d 7753 to 8184 436 to 4       433/436
(99 %)
0 diff
(100 %id)
AI870943 anaplastic oligodendroglioma, brain .d 7755 to 8191 442 to 6       437/442
(98 %)
0 diff
(100 %id)
BF999940 placenta_normal .d 7759 to 7976 250 to 33       218/268
(81 %)
0 diff
(100 %id)
AI318067 adenocarcinoma, colon .d 7759 to 8184 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA831632 germinal center B cell .d 7761 to 8184 442 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
AI038170   .d 7778 to 8184 410 to 4       407/410
(99 %)
0 diff
(100 %id)
AI767891 2 pooled tumors (clear cell type), Kidney .d 7779 to 8192 446 to 33       414/446
(92 %)
0 diff
(100 %id)
BF445371 carcinoid, lung .d 7779 to 8184 409 to 4       406/409
(99 %)
0 diff
(100 %id)
AI675876 Prostate .d 7785 to 8187 429 to 26   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 404/404
(100 %)
3 diff
(99.3 %id)
AA968829 carcinoid, lung .d 7788 to 8183 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AI282815 esophagus, squamous cell carcinoma .d 7790 to 8191 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI627602 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 7791 to 8184 421 to 28   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 394/394
(100 %)
2 diff
(99.5 %id)
AW440943 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .d 7797 to 8078 282 to 1       282/282
(100 %)
0 diff
(100 %id)
BE218912 carcinoid, lung .d 7797 to 8183 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AA635846 normal prostate, Prostate .d 7807 to 8189 404 to 22   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 383/383
(100 %)
3 diff
(99.3 %id)
AA553463 Schwannoma tumor .d 7808 to 8184 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AI199988 lung .d 7810 to 8184 381 to 7       375/381
(98 %)
0 diff
(100 %id)
N93794 lung .d 7813 to 8184 380 to 2     Submitted on the opposite strand 379/502
(75 %)
0 diff
(100 %id)
BU676266 lung, Primary Lung Epithelial Cells .d 7818 to 8187 10 to 379   AAA Submitted on the opposite strand 370/379
(97 %)
6 diff
(98.5 %id)
AA749023 germinal center B cell .d 7826 to 8184 375 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 359/360
(99 %)
1 diff
(99.8 %id)
AI857382 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 7826 to 8184 359 to 1       359/370
(97 %)
0 diff
(100 %id)
H99417 melanocyte .d 7839 to 8184 349 to 1       349/363
(96 %)
5 diff
(98.7 %id)
FN146878 breast carcinoma .d 7842 to 7945 104 to 1     Submitted on the opposite strand 104/104
(100 %)
1 diff
(99.1 %id)
AI382442   .d 7846 to 8184 345 to 5       341/345
(98 %)
0 diff
(100 %id)
AI689709 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 7849 to 8184 342 to 7       336/342
(98 %)
0 diff
(100 %id)
AI675547 Prostate .d 7866 to 8189 350 to 27   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 324/324
(100 %)
0 diff
(100 %id)
AA045565 uterus .d 7900 to 8184 285 to 1       285/285
(100 %)
0 diff
(100 %id)
CN426965 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 7929 to 8101 173 to 1     Submitted on the opposite strand 173/173
(100 %)
3 diff
(98.3 %id)
N66560 multiple sclerosis lesions .d 7944 to 8185 242 to 1   fully sequenced,   242/242
(100 %)
1 diff
(99.6 %id)
AI927173 Kidney .d 7952 to 8123 172 to 1       172/172
(100 %)
0 diff
(100 %id)
AA243347 germinal center B cell .d 7968 to 8191 226 to 3       224/226
(99 %)
0 diff
(100 %id)
AW079599 colon, moderately differentiated adenocarcinoma .d 7973 to 8191 222 to 3       220/223
(98 %)
0 diff
(100 %id)
AA405516   .d 8043 to 8184 148 to 7       142/148
(95 %)
0 diff
(100 %id)
EC443337 Prostate .d 8063 to 8171 1 to 111       111/111
(100 %)
4 diff
(96.4 %id)
FN095683 breast carcinoma .d 8079 to 8140 1 to 61       61/62
(98 %)
4 diff
(93.6 %id)
BC040231 Skin, normal .e 1 to 3234 1 to 3234 R136I tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 3234/3234
(100 %)
1 diff
(100.0 %id)
TI_1948087869   .e 193 to 1057 128 to 1000       873/1363
(64 %)
30 diff
(97.8 %id)
TI_1948087531   .e 198 to 1033 140 to 981       842/1487
(56 %)
26 diff
(98.3 %id)
TI_1948087532   .e 1995 to 2802 955 to 134       822/1343
(61 %)
57 diff
(95.8 %id)
TI_1948087870   .e 2054 to 2802 887 to 132       753/1387
(54 %)
21 diff
(98.5 %id)
AK000295   .f 1 to 2030 1 to 2030 I272V tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (19/23 A in genome downstream of last aligned base) 2030/2030
(100 %)
2 diff
(100.0 %id)
NM_024668.2   .g 1 to 2144 1 to 2144 exact RefSeq, AAA   2144/2144
(100 %)
0 diff
(100 %id)
AF258557   .g 11 to 2141 1 to 2131 exact tiling clone, AAA   2131/2131
(100 %)
0 diff
(100 %id)
BJ989470 hepatoblastoma .g 22 to 604 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BC004457 Lung, small cell carcinoma .g 26 to 2144 1 to 2119 exact available from MGC, AAA   2119/2119
(100 %)
0 diff
(100 %id)
BC009909 Lung, small cell carcinoma .g 26 to 2144 1 to 2119 L175M G228C available from MGC, AAA   2119/2119
(100 %)
3 diff
(99.9 %id)
BC150486 PCR rescued clones .g 41 to 2080 1 to 2040 exact     2040/2040
(100 %)
4 diff
(99.9 %id)
BC117677 PCR rescued clones .g 45 to 2080 1 to 2036 exact     2036/2036
(100 %)
0 diff
(100 %id)
BC127127 PCR rescued clones .g 45 to 2080 1 to 2036 exact     2036/2036
(100 %)
0 diff
(100 %id)
AL514696 neuroblastoma, placenta .g 145 to 996 1 to 852       852/852
(100 %)
1 diff
(99.9 %id)
AK022041 whole embryo, mainly body .g 435 to 2144 1 to 1710   available from FLJ, AAA   1710/1710
(100 %)
2 diff
(99.9 %id)
AU120725 whole embryo, mainly body .g 436 to 1270 2 to 831   capped   830/872
(95 %)
10 diff
(98.9 %id)
TI_1948078897   .g 701 to 1334 127 to 761   fully sequenced,   635/761
(83 %)
8 diff
(99.0 %id)
TI_1948079241   .g 701 to 1309 129 to 737   fully sequenced,   609/737
(82 %)
6 diff
(99.2 %id)
TI_1948079939   .g 1037 to 2007 1105 to 129       977/1317
(74 %)
20 diff
(98.5 %id)
TI_1948079589   .g 1065 to 2007 1069 to 128       942/1279
(73 %)
9 diff
(99.3 %id)
BX342814   .g 1086 to 2112 1022 to 4       1019/1034
(98 %)
36 diff
(96.6 %id)
TI_1948079590   .g 1261 to 2007 870 to 125       746/1095
(68 %)
6 diff
(99.5 %id)
TI_1948079940   .g 1261 to 2007 861 to 123       739/1119
(66 %)
18 diff
(98.4 %id)
TI_1948079242   .g 1279 to 2007 853 to 125   fully sequenced,   729/853
(85 %)
1 diff
(99.9 %id)
TI_1948078898   .g 1304 to 2007 826 to 123   fully sequenced,   704/826
(85 %)
0 diff
(100 %id)
TI_149304887   .g 1362 to 2144 864 to 89   AAA   776/942
(82 %)
12 diff
(98.8 %id)
BU632488 cell lines, Chondrosarcoma .g 1362 to 2144 801 to 19   AAA   783/783
(100 %)
0 diff
(100 %id)
AL514695 neuroblastoma, placenta .g 1366 to 2145 780 to 1       780/784
(99 %)
17 diff
(97.9 %id)
BE622787 melanotic melanoma, skin .g 1387 to 2085 727 to 4       724/1064
(68 %)
24 diff
(97.8 %id)
BU622224 Cell Line, Chondrosarcoma .g 1398 to 2144 764 to 19   AAA   746/746
(100 %)
4 diff
(99.5 %id)
BG460754   .g 1437 to 2126 703 to 19     Submitted on the opposite strand 685/943
(72 %)
44 diff
(95.4 %id)
BE967248 melanotic melanoma, skin .g 1444 to 2144 710 to 16   AAA   695/755
(92 %)
40 diff
(94.8 %id)
BI850681 duodenal adenocarcinoma, cell line, small intestine .g 1472 to 2141 672 to 1     Submitted on the opposite strand 672/672
(100 %)
4 diff
(99.5 %id)
BM978395 lung, Primary Lung Epithelial Cells .g 1508 to 2144 653 to 19   AAA   635/635
(100 %)
1 diff
(99.9 %id)
AW247150 lung, small cell carcinoma .g 1540 to 2144 615 to 11   available from MGC, AAA   605/605
(100 %)
1 diff
(99.9 %id)
BJ989471 hepatoblastoma .g 1579 to 2118 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AI732616   .g 1610 to 2144 535 to 1       535/535
(100 %)
0 diff
(100 %id)
AU146714 whole embryo, mainly body .g 1629 to 2144 540 to 27   AAA   514/517
(99 %)
15 diff
(97.1 %id)
DB338586 testis .g 1629 to 2141 513 to 1       513/514
(99 %)
1 diff
(99.9 %id)
CR987023 T-Lymphocytes .g 1637 to 2144 1 to 508   AAA   508/508
(100 %)
0 diff
(100 %id)
AA169412   .g 1750 to 2144 402 to 1       402/402
(100 %)
7 diff
(98.3 %id)
BG208883   .g 1840 to 2092 254 to 4     Submitted on the opposite strand 251/254
(98 %)
0 diff
(100 %id)
BG272376 head/neck, nasopharyngeal carcinoma .g 1918 to 2141 230 to 7       224/261
(85 %)
0 diff
(100 %id)
NM_017978.1   .h 1 to 2111 1 to 2111 exact RefSeq, AAA   2111/2111
(100 %)
0 diff
(100 %id)
TI_57236458   .h 38 to 743 34 to 739   tiling clone,   706/739
(95 %)
7 diff
(99.1 %id)
BI911057 leukocyte .h 39 to 743 1 to 705       705/705
(100 %)
1 diff
(99.9 %id)
BC009420 Lung, small cell carcinoma .h 78 to 2111 1 to 2034 exact tiling clone, available from MGC, AAA   2034/2034
(100 %)
0 diff
(100 %id)
CV030079 mixed .h 125 to 761 1 to 634       634/634
(100 %)
3 diff
(99.6 %id)
TI_1948095083   .h 125 to 1005 130 to 1023       894/1387
(64 %)
38 diff
(97.3 %id)
TI_1948095243   .h 125 to 994 129 to 1002       874/1394
(62 %)
26 diff
(98.2 %id)
BE264197 lung, small cell carcinoma .h 308 to 744 233 to 679   available from MGC,   636/793
(80 %)
30 diff
(96.3 %id)
TI_1948095084   .h 1004 to 1974 1096 to 128       969/1251
(77 %)
31 diff
(97.6 %id)
TI_1948095244   .h 1097 to 1974 1006 to 126       881/1296
(67 %)
33 diff
(97.5 %id)
BQ425318 eye, retinoblastoma .i 1 to 801 1 to 805   tiling clone,   805/902
(89 %)
15 diff
(98.4 %id)
TI_57168545   .i 14 to 795 28 to 807       780/808
(96 %)
13 diff
(98.4 %id)
BX332460 Neuroblastoma Cot 25-normalized .i 15 to 997 1 to 981   tiling clone,   981/1065
(92 %)
8 diff
(99.3 %id)
BI833131 pooled pancreas and spleen .i 20 to 795 1 to 775       775/776
(99 %)
7 diff
(99.1 %id)
BG576105 breast, mammary adenocarcinoma, cell line .i 27 to 700 1 to 679       679/870
(78 %)
13 diff
(98.6 %id)
CK005836 brain/CNS, Human Brain - Frontal Cortex .i 389 to 997 1 to 610       610/621
(98 %)
6 diff
(99.1 %id)
BF312591 brain, neuroblastoma .i 396 to 1228 1 to 829   tiling clone,   829/841
(98 %)
23 diff
(97.3 %id)
BI199980 brain, neuroblastoma .i 396 to 915 1 to 520       520/521
(99 %)
8 diff
(98.5 %id)
AW505092 lymph .i 432 to 775 35 to 379       345/379
(91 %)
16 diff
(95.8 %id)
TI_154161605   .i 432 to 978 99 to 646       548/575
(95 %)
31 diff
(94.7 %id)
BG425018 Kidney, renal cell adenocarcinoma .i 464 to 1084 1 to 628       628/1024
(61 %)
12 diff
(98.9 %id)
BX332459 Neuroblastoma Cot 25-normalized .i 1025 to 2070 1035 to 6   tiling clone,   1030/1041
(98 %)
31 diff
(97.1 %id)
DB031638 testis .j 1 to 611 2 to 613   tiling clone, capped   612/612
(100 %)
1 diff
(99.9 %id)
DB337074 testis .j 1986 to 2531 548 to 1   tiling clone,   548/548
(100 %)
3 diff
(99.5 %id)
AB029008 brain .k 1 to 5455 1 to 5455 exact tiling clone, available from KIAA,   5455/5455
(100 %)
2 diff
(100.0 %id)
T82868 liver and spleen .k 1134 to 1502 1 to 379       379/432
(87 %)
20 diff
(95.4 %id)
DR763440 embryonic stem .k 1180 to 2000 1 to 821       821/821
(100 %)
1 diff
(99.9 %id)
CB956398 Pooled-Glandular .k 1574 to 2291 1 to 730       730/731
(99 %)
21 diff
(97.2 %id)
TI_149293613   .k 1703 to 2507 887 to 84   AAA   804/1016
(79 %)
7 diff
(99.4 %id)
BU682734 lung .k 1808 to 2507 718 to 19   AAA   700/700
(100 %)
0 diff
(100 %id)
DB230313 trachea .k 1824 to 2413 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
BX954102   .k 2298 to 2945 1 to 648       648/648
(100 %)
2 diff
(99.7 %id)
BQ015180 Chondrosarcoma, Left Pubic Bone .k 4724 to 5450 740 to 15   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 726/726
(100 %)
1 diff
(99.9 %id)
T90282 liver and spleen .k 5019 to 5425 412 to 1       412/422
(97 %)
11 diff
(97.4 %id)
BC117678 PCR rescued clones .l 1 to 1926 1 to 1926 exact tiling clone,   1926/1926
(100 %)
0 diff
(100 %id)
AK024056   .m 1 to 1598 5 to 1601 Y233C I268F S269L L271* tiling clone, available from FLJ,   1601/1601
(100 %)
3 diff
(99.9 %id)
AU143608   .m 1 to 800 5 to 804   capped   803/803
(100 %)
6 diff
(99.3 %id)
BI092186 cervix .m 88 to 766 1 to 677   tiling clone,   677/677
(100 %)
6 diff
(99.2 %id)
AU160676   .m 1031 to 1598 560 to 1       560/563
(99 %)
19 diff
(96.7 %id)
AA465291 germinal center B cell .n 1 to 451 1 to 451   tiling clone,   451/451
(100 %)
5 diff
(98.9 %id)
R60629 whole brain .n 104 to 527 1 to 432   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 432/485
(89 %)
15 diff
(97.0 %id)
BG763688 melanotic melanoma, high MDR (cell line), skin .n 290 to 917 1 to 636       636/637
(99 %)
13 diff
(98.0 %id)
BP329796 rectum .n 317 to 900 1 to 583       583/583
(100 %)
13 diff
(97.8 %id)
CR982210 T-Lymphocytes .n 380 to 1198 1 to 820   tiling clone,   820/826
(99 %)
12 diff
(98.6 %id)
AA334472   .n 472 to 825 11 to 365       355/366
(96 %)
8 diff
(97.9 %id)
R94251 liver and spleen .n 585 to 973 1 to 393       393/423
(92 %)
11 diff
(97.4 %id)
R60576 whole brain .n 1149 to 1586 458 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 440/442
(99 %)
11 diff
(97.6 %id)
AA465173 germinal center B cell .n 1222 to 1583 363 to 2   tiling clone,   362/363
(99 %)
0 diff
(100 %id)
R94611 liver and spleen .n 1255 to 1552 317 to 10       308/335
(91 %)
0 diff
(100 %id)
BQ882595 lymph, lymphoma, cell line .o 1 to 895 11 to 907   tiling clone,   895/946
(94 %)
38 diff
(96.0 %id)
BG759179 B-cells, primary B-cells from tonsils (cell line) .o 237 to 1121 1 to 887   tiling clone,   887/887
(100 %)
22 diff
(97.6 %id)
BM806974 duodenal adenocarcinoma, cell line, small intestine .p 1 to 850 11 to 863 A264C D265* tiling clone,   853/1023
(83 %)
12 diff
(98.9 %id)
CU442791 epidermis .q 1 to 613 624 to 2 E201Q K203E G204D tiling clone, Submitted on the opposite strand 618/624
(99 %)
0 diff
(100 %id)
TI_154078134   .q 49 to 541 561 to 74       488/561
(86 %)
0 diff
(100 %id)
AW965472   .r 1 to 609 9 to 614 G162S S166F H176Y P177S G184K ... tiling clone,   606/624
(97 %)
21 diff
(96.7 %id)
AW243029 Kidney .s 1 to 578 579 to 2 T62Q I63* tiling clone,   578/579
(99 %)
2 diff
(99.7 %id)
N52683 multiple sclerosis lesions .t 1 to 246 10 to 260   tiling clone,   251/260
(96 %)
12 diff
(95.4 %id)
AI061582 Liver .t 12 to 658 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
CA394692 eye, RPE/choroid .t 13 to 646 1 to 634   tiling clone,   634/634
(100 %)
0 diff
(100 %id)
AV726610 hypothalamus .t 151 to 829 1 to 677       677/751
(90 %)
14 diff
(98.2 %id)
AV727485 hypothalamus .t 151 to 633 1 to 483       483/483
(100 %)
0 diff
(100 %id)
AA487348 lung .t 302 to 823 1 to 517   fully sequenced,   517/517
(100 %)
8 diff
(98.5 %id)
N49755 multiple sclerosis lesions .t 361 to 848 495 to 1       495/495
(100 %)
16 diff
(96.8 %id)
BP395314 pancreatic islet .t 385 to 852 1 to 469     Submitted on the opposite strand 469/469
(100 %)
1 diff
(99.8 %id)
T87261 liver and spleen .t 385 to 650 1 to 276   fully sequenced,   276/276
(100 %)
9 diff
(96.8 %id)
AI218622   .t 404 to 848 470 to 26   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 445/445
(100 %)
2 diff
(99.6 %id)
AA506341 colon .t 444 to 851 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA847761 colon, colon tumor .t 451 to 859 409 to 1   tiling clone,   409/409
(100 %)
0 diff
(100 %id)
AI040988   .t 454 to 851 398 to 1       398/398
(100 %)
3 diff
(99.3 %id)
AW468198 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .t 485 to 854 370 to 1       370/370
(100 %)
0 diff
(100 %id)
CB136867 Liver .t 534 to 848 1 to 315   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 315/315
(100 %)
0 diff
(100 %id)
AA487233 lung .t 584 to 847 264 to 1   fully sequenced,   264/264
(100 %)
0 diff
(100 %id)
C75169   .t 605 to 857 253 to 1       253/253
(100 %)
1 diff
(99.7 %id)
T87176 liver and spleen .t 620 to 851 236 to 1   fully sequenced,   236/236
(100 %)
1 diff
(99.6 %id)
DT219630 brain .u 1 to 632 1 to 631 exact tiling clone,   631/631
(100 %)
2 diff
(99.7 %id)
DB091465 testis .va 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
CR984364 T-Lymphocytes .vb 1 to 829 1 to 828 exact tiling clone,   828/828
(100 %)
1 diff
(99.9 %id)
BU628392 cell lines, Chondrosarcoma .vc 1 to 660 678 to 19 S6C tiling clone, AAA   660/660
(100 %)
4 diff
(99.4 %id)
DR006161 Prostate .vd 1 to 587 29 to 616 exact tiling clone,   588/616
(95 %)
8 diff
(98.8 %id)
AF038869   .vd 10 to 695 1 to 687   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 687/687
(100 %)
3 diff
(99.6 %id)
NM_003732.2   .vd 10 to 700 1 to 691   RefSeq, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 691/691
(100 %)
0 diff
(100 %id)
BC010881 Lymph, Burkitt lymphoma .vd 14 to 700 1 to 687   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 687/687
(100 %)
0 diff
(100 %id)
CK430632 eye, lacrimal gland .vd 16 to 630 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BP275545 Kidney .vd 23 to 603 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BM790263 Ascites, stomach .vd 23 to 678 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BC069293 PCR rescued clones .vd 32 to 434 1 to 403   available from MGC,   403/403
(100 %)
1 diff
(99.8 %id)
BE396896 Burkitt lymphoma, lymph .vd 32 to 693 1 to 661       661/722
(91 %)
3 diff
(99.6 %id)
BE267670 Burkitt lymphoma, lymph .vd 33 to 691 1 to 657       657/673
(97 %)
4 diff
(99.5 %id)
BE269478 Burkitt lymphoma, lymph .vd 33 to 695 1 to 659   available from MGC,   659/659
(100 %)
7 diff
(99.0 %id)
BE397051 Burkitt lymphoma, lymph .vd 33 to 654 1 to 621       621/622
(99 %)
2 diff
(99.7 %id)
BC073751 Lymph, lymphoma .vd 35 to 691 1 to 657   available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 657/657
(100 %)
0 diff
(100 %id)
BQ057148 lymph, lymphoma, cell line .vd 37 to 690 1 to 654   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 654/656
(99 %)
1 diff
(99.9 %id)
BQ058446 lymph, lymphoma, cell line .vd 37 to 691 1 to 655   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 655/655
(100 %)
0 diff
(100 %id)
CD675172 eye, lens .vd 51 to 696 1 to 646       646/646
(100 %)
0 diff
(100 %id)
CV030037 mixed .vd 82 to 263 1 to 182       182/182
(100 %)
15 diff
(91.8 %id)
BM727588 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vd 95 to 386 1 to 292   fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 292/292
(100 %)
0 diff
(100 %id)
Z25258 leg muscle, skeletal muscle .vd 97 to 422 10 to 337       328/340
(96 %)
18 diff
(94.8 %id)
TI_151731577   .vd 112 to 695 662 to 79   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 584/960
(60 %)
0 diff
(100 %id)
BQ189300 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vd 113 to 683 1 to 571   fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 571/571
(100 %)
0 diff
(100 %id)
AI082253 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vd 124 to 695 572 to 1       572/572
(100 %)
1 diff
(99.9 %id)
AI829379 adenocarcinoma, Pancreas .vd 129 to 695 579 to 13   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 567/567
(100 %)
14 diff
(97.6 %id)
CK299454 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vd 255 to 695 459 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
BM681809 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vd 325 to 695 385 to 15   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 371/371
(100 %)
0 diff
(100 %id)
DA499739 brain .ve 1 to 473 2 to 474 exact tiling clone, capped   473/473
(100 %)
0 diff
(100 %id)
DB455192 testis .vf -9 to 464 1 to 474 E30* tiling clone, Submitted on the opposite strand 474/474
(100 %)
4 diff
(99.2 %id)
DB520601 testis .vf 765 to 1232 1 to 468   tiling clone, Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
AK024213 mammary gland .vg-u 1 to 2405 2 to 2406 exact tiling clone, available from FLJ,   2406/2406
(100 %)
4 diff
(99.9 %id)
AU122745 mammary gland .vg-u 1 to 866 2 to 864 V85G P91S capped   863/864
(99 %)
10 diff
(98.9 %id)
AU148255 mammary gland .vg-u 1884 to 2405 525 to 1       525/525
(100 %)
22 diff
(95.9 %id)
TI_149284619   .vg-u 1938 to 2433 531 to 36       496/1201
(41 %)
0 diff
(100 %id)
BU680623 lung, Primary Lung Epithelial Cells .vg-u 1938 to 2405 484 to 17   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 468/474
(98 %)
3 diff
(99.4 %id)
AA468583 colon .vg-u 2034 to 2408 375 to 1       375/375
(100 %)
0 diff
(100 %id)
AA947385 ovary .vg-u 2146 to 2417 272 to 1       272/272
(100 %)
3 diff
(98.9 %id)
DW410867 Liver .vg-u 2147 to 2428 315 to 29       287/331
(86 %)
0 diff
(100 %id)
DW449485 Liver .vg-u 2147 to 2333 17 to 203       187/203
(92 %)
6 diff
(97.1 %id)
FN166730 breast carcinoma .vg-u 2190 to 2287 95 to 1     Submitted on the opposite strand 95/102
(93 %)
4 diff
(96.1 %id)
BF903443 marrow .vg-u 2248 to 2551 305 to 1     Submitted on the opposite strand 305/305
(100 %)
37 diff
(87.9 %id)
DA558153   .vg-u 2262 to 2826 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
BX956832   .vg-u 2485 to 3154 1 to 669   tiling clone,   669/669
(100 %)
5 diff
(99.3 %id)
AK310086 Spleen .vg-u 2980 to 3901 1 to 922   tiling clone,   922/922
(100 %)
1 diff
(99.9 %id)
DA943815 Spleen .vg-u 2981 to 3552 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA117411 cerebellum .vg-u 3885 to 4449 2 to 572   tiling clone, capped   571/571
(100 %)
6 diff
(99.0 %id)
BF771628 epid_tumor .vh 1 to 313 323 to 12 K44* tiling clone, Submitted on the opposite strand 312/329
(94 %)
11 diff
(96.7 %id)
CD642571 Embryonic Stem cells .vi 1 to 493 310 to 802 exact tiling clone,   493/802
(61 %)
12 diff
(98.6 %id)
CV571127 cornea, eye .vi 46 to 555 1 to 510   tiling clone,   510/510
(100 %)
1 diff
(99.9 %id)
BF374542 stomach .vj 1 to 215 232 to 20 K60R Y64* tiling clone,   213/232
(91 %)
0 diff
(100 %id)
BF964052 nervous_normal .vk 88 to 423 22 to 359 C12G tiling clone,   338/393
(86 %)
10 diff
(97.5 %id)
AI375217 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vk 150 to 697 548 to 1 D5A R6E S15L I17L L25F tiling clone,   548/548
(100 %)
12 diff
(97.9 %id)
AA478608 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vk 249 to 697 449 to 1   tiling clone, fully sequenced,   449/449
(100 %)
0 diff
(100 %id)
BF509603   .vl-u 371 to 740 385 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 370/380
(97 %)
0 diff
(100 %id)
C05170 heart .vl-u 1153 to 1552 400 to 1   tiling clone,   400/400
(100 %)
0 diff
(100 %id)
H30831 eye, retina .vl-u 1203 to 1378 1 to 179       179/179
(100 %)
7 diff
(96.1 %id)
BM995553 lung, Metastatic Chondrosarcoma .vl-u 1289 to 1921 14 to 646   tiling clone, Submitted on the opposite strand 633/662
(95 %)
4 diff
(99.4 %id)
BM661670 eye, Retina Foveal and Macular .vl-u 1325 to 1641 1 to 317   fully sequenced, Submitted on the opposite strand 317/317
(100 %)
2 diff
(99.4 %id)
BF110219 carcinoid, lung .vl-u 1387 to 1857 1 to 471     Submitted on the opposite strand 471/471
(100 %)
3 diff
(99.4 %id)
AI701775 carcinoid, lung .vl-u 1391 to 1737 1 to 347     Submitted on the opposite strand 347/347
(100 %)
2 diff
(99.5 %id)
BM689703 eye, Retina Foveal and Macular .vl-u 1570 to 1645 77 to 2   fully sequenced, AAA Submitted on the opposite strand 76/77
(98 %)
5 diff
(93.6 %id)
BG620446 placenta .vl-u 1986 to 2295 1 to 310   tiling clone,   310/310
(100 %)
0 diff
(100 %id)
H30747 eye, retina .vl-u 2039 to 2269 231 to 1       231/231
(100 %)
2 diff
(99.2 %id)
BG745947 Spleen .vl-u 2090 to 2785 710 to 1   tiling clone, fully sequenced,   710/710
(100 %)
5 diff
(99.3 %id)
BG745667 Spleen .vl-u 2104 to 2247 372 to 516   fully sequenced,   484/484
(100 %)
17 diff
(96.5 %id)
AA196275   .vl-u 2196 to 2648 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AW973402   .vl-u 2245 to 2831 588 to 1   tiling clone, Submitted on the opposite strand 588/588
(100 %)
20 diff
(96.6 %id)
AA634242 lung .vl-u 2346 to 2806 461 to 1       461/461
(100 %)
1 diff
(99.8 %id)
AA552947 Schwannoma tumor .vl-u 2387 to 2806 419 to 1       419/419
(100 %)
5 diff
(98.9 %id)
T64196 lung .vl-u 2473 to 2838 366 to 1       366/366
(100 %)
7 diff
(98.1 %id)
AK022433 mammary gland .vm-u 1 to 2052 2 to 2053 exact tiling clone, available from FLJ,   2053/2053
(100 %)
2 diff
(100.0 %id)
AU122470 mammary gland .vm-u 1 to 900 2 to 895   capped   894/898
(99 %)
11 diff
(98.8 %id)
DA864400 placenta .vm-u 25 to 591 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CA777177 Pancreas, Purified pancreatic islet .vm-u 118 to 618 1 to 500       500/500
(100 %)
7 diff
(98.6 %id)
AA348794 adrenal gland .vm-u 934 to 1235 1 to 304       304/304
(100 %)
4 diff
(98.7 %id)
AA297573 brain, frontal cortex .vm-u 968 to 1265 9 to 307       299/307
(97 %)
2 diff
(99.4 %id)
R02731 liver and spleen .vm-u 1306 to 1711 1 to 412   tiling clone,   412/416
(99 %)
12 diff
(97.2 %id)
AU148042 mammary gland .vm-u 1495 to 2052 556 to 1 L10X P11H S12P I13L D14T ...     556/556
(100 %)
5 diff
(99.2 %id)
AA487327 lung .vm-u 1506 to 1802 1 to 297   fully sequenced,   297/297
(100 %)
0 diff
(100 %id)
CA776893 Pancreas, Purified pancreatic islet .vm-u 1521 to 2055 535 to 1   tiling clone,   535/535
(100 %)
7 diff
(98.7 %id)
R02732 liver and spleen .vm-u 1717 to 2050 343 to 6       338/348
(97 %)
0 diff
(100 %id)
AA487174 lung .vm-u 1772 to 2052 281 to 1   tiling clone, fully sequenced,   281/281
(100 %)
1 diff
(99.7 %id)
BG433372 Kidney .vn-u 1 to 729 1 to 733   tiling clone,   733/740
(99 %)
20 diff
(97.3 %id)
BG536805 lung .vn-u 684 to 1325 1 to 644   tiling clone,   644/644
(100 %)
7 diff
(99.0 %id)
AI761566 pooled .vn-u 1211 to 1783 573 to 1   tiling clone,   573/573
(100 %)
6 diff
(99.0 %id)
AA832124 germinal center B cell .vn-u 1370 to 1713 344 to 1   tiling clone,   344/344
(100 %)
0 diff
(100 %id)
TI_149296870   .vo-u 1 to 781 863 to 93   tiling clone, AAA   771/817
(94 %)
26 diff
(96.9 %id)
BU684493 lung, Primary Lung Cystic Fibrosis EpithelialCells .vo-u 202 to 781 597 to 19   tiling clone, AAA   579/579
(100 %)
1 diff
(99.9 %id)
CB052730 leiomyosarcoma, soft tissue .vo-u 230 to 624 5 to 399   tiling clone, fully sequenced,   395/399
(98 %)
11 diff
(97.3 %id)
AW020205 cochlea, ear .vo-u 431 to 594 1 to 164   fully sequenced,   164/164
(100 %)
5 diff
(97.0 %id)
AW020246 cochlea, ear .vo-u 431 to 629 1 to 199   fully sequenced,   199/199
(100 %)
5 diff
(97.5 %id)
BI491993 cochlea, ear .vo-u 527 to 1193 667 to 1 exact     667/667
(100 %)
0 diff
(100 %id)
BI491241 cochlea, ear .vo-u 564 to 1198 652 to 18 exact tiling clone, fully sequenced, AAA   635/635
(100 %)
0 diff
(100 %id)
CB052729 leiomyosarcoma, soft tissue .vo-u 594 to 1198 647 to 43 exact fully sequenced, AAA   605/605
(100 %)
1 diff
(99.9 %id)
BI491304 cochlea, ear .vo-u 599 to 1198 617 to 18 exact fully sequenced, AAA   600/600
(100 %)
0 diff
(100 %id)
BX115269 pooled .vo-u 800 to 1193 1 to 394 exact     394/394
(100 %)
0 diff
(100 %id)
AI827613 pooled .vo-u 833 to 1193 376 to 13 exact     364/376
(96 %)
0 diff
(100 %id)
AW362539 colon .vo-u 866 to 1390 15 to 537 W9G N10I K11R I12S R13V ... tiling clone,   523/556
(94 %)
15 diff
(97.4 %id)
BF222312 Prostate .vo-u 883 to 1198 332 to 17 M27I AAA   316/316
(100 %)
2 diff
(99.4 %id)
AA527391 colon .vp 1 to 470 474 to 1   tiling clone,   474/474
(100 %)
2 diff
(99.6 %id)
BY997015   .vp 333 to 972 1 to 640 exact tiling clone,   640/640
(100 %)
0 diff
(100 %id)
FN100794 breast carcinoma .vq 1 to 117 116 to 1   tiling clone, Submitted on the opposite strand 116/116
(100 %)
1 diff
(99.2 %id)
AA046468 eye, retina .vq 34 to 593 1 to 556 L9P L42X tiling clone, Submitted on the opposite strand 556/605
(91 %)
13 diff
(97.9 %id)
AA015992 eye, retina .vq 36 to 373 1 to 341     Submitted on the opposite strand 341/346
(98 %)
4 diff
(98.9 %id)
AA019993 eye, retina .vq 36 to 673 1 to 634 exact   Submitted on the opposite strand 634/638
(99 %)
20 diff
(96.9 %id)
AA057438 eye, retina .vq 36 to 659 1 to 613 exact tiling clone, Submitted on the opposite strand 613/683
(89 %)
18 diff
(97.4 %id)
AI418259 pooled .vq 564 to 925 362 to 1   tiling clone,   362/362
(100 %)
0 diff
(100 %id)
AV695735 hepatocellular carcinoma .vr 14 to 363 1 to 350   tiling clone,   350/370
(94 %)
1 diff
(99.8 %id)
AV698833 hepatocellular carcinoma .vr 14 to 363 1 to 348       348/359
(96 %)
1 diff
(99.8 %id)
BF681377 Prostate .vr 135 to 618 193 to 670   tiling clone,   478/859
(55 %)
20 diff
(97.7 %id)
DA490925 brain .vr 383 to 903 2 to 522 exact tiling clone, capped   521/521
(100 %)
0 diff
(100 %id)
AW895232 nervous_normal .vr 505 to 553 53 to 4       499/565
(88 %)
15 diff
(97.4 %id)
T07216   .vr 540 to 871 1 to 332       332/332
(100 %)
0 diff
(100 %id)
BG434919 placenta .vs-u 1 to 721 1 to 719 exact tiling clone,   719/719
(100 %)
4 diff
(99.5 %id)
AI783650 Kidney .vt-u 1 to 280 280 to 1 exact tiling clone,   280/400
(70 %)
0 diff
(100 %id)
BU617619 Bone, Subchondral Bone .vt-u 104 to 663 578 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 560/569
(98 %)
5 diff
(99.2 %id)
GD137569   .vt-u 122 to 291 1 to 171       171/175
(97 %)
4 diff
(97.8 %id)
DA100515 cerebellum .vu-u 1 to 574 2 to 593   tiling clone, capped   592/592
(100 %)
6 diff
(99.0 %id)
BE972400 testis .vv-u 1 to 309 1 to 306 L15W V16S L18S R20E E21N ... tiling clone,   306/808
(37 %)
9 diff
(98.9 %id)
BE242801 leukopheresis .vv-u 274 to 532 1 to 258   tiling clone,   258/258
(100 %)
3 diff
(98.9 %id)
BM828329 Ascites, stomach .vw 1 to 474 1 to 474 exact tiling clone,   474/474
(100 %)
0 diff
(100 %id)
GD159673   .vx-u 1 to 176 952 to 773   tiling clone, Submitted on the opposite strand 180/959
(18 %)
0 diff
(100 %id)
Z19207 leg muscle, skeletal muscle .vx-u 156 to 459 309 to 1   tiling clone,   309/321
(96 %)
9 diff
(97.2 %id)
DR979199 placenta .vx-u 197 to 459 1 to 262   AAA Submitted on the opposite strand 262/262
(100 %)
13 diff
(95.1 %id)
AW954266   .vx-u 198 to 463 1 to 266   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 266/266
(100 %)
0 diff
(100 %id)
F00309 leg muscle, skeletal muscle .vx-u 201 to 459 259 to 1       259/259
(100 %)
0 diff
(100 %id)
BQ012791 placenta .vx-u 290 to 463 187 to 14   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 174/174
(100 %)
0 diff
(100 %id)
BG055660 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .vy-u 1 to 340 340 to 1 exact tiling clone,   340/340
(100 %)
0 diff
(100 %id)
BE087398 breast .vz-u 1 to 255 259 to 6 exact tiling clone, Submitted on the opposite strand 254/259
(98 %)
0 diff
(100 %id)
AA554651 normal prostatic epithelial cells, Prostate .vz-u 8 to 140 143 to 11       133/147
(90 %)
0 diff
(100 %id)
BQ342864 nervous_normal .wa 1 to 252 21 to 279 E24R P25T D26E G27M L28D ... tiling clone,   259/294
(88 %)
13 diff
(95.6 %id)
DA069229 cerebellum Gene ANKHD1-EIF4EBP3, variant not shown       capped      
CA392803 eye, RPE/choroid Gene ANKHD1-EIF4EBP3, variant not shown              
DW439834 Liver Gene ANKHD1-EIF4EBP3, variant not shown              
DB319680 lung Gene ANKHD1-EIF4EBP3, variant not shown              
DA595848 lung Gene ANKHD1-EIF4EBP3, variant not shown       capped      
AA230210   Gene ANKHD1-EIF4EBP3, variant not shown              
AW003940 pooled germ cell tumors Gene ANKHD1-EIF4EBP3, variant not shown       AAA Submitted on the opposite strand, submitted on the opposite strand    
AW075578 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney Gene ANKHD1-EIF4EBP3, variant not shown              
BG285563 bladder, transitional cell papilloma, cell line Gene ANKHD1-EIF4EBP3, variant not shown              
263 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg-u, .vh, .vi, .vj, .vk, .vl-u, .vm-u, .vn-u, .vo-u, .vp, .vq, .vr, .vs-u, .vt-u, .vu-u, .vv-u, .vw, .vx-u, .vy-u, .vz-u, .wa Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI